287 related articles for article (PubMed ID: 7479444)
1. [Regulation of the cell cycle--involvement of protein inhibitors of cyclin-dependent kinases].
Grzelakowska-Sztabert B
Postepy Biochem; 1995; 41(2):80-93. PubMed ID: 7479444
[No Abstract] [Full Text] [Related]
2. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.
Gray-Bablin J; Rao S; Keyomarsi K
Cancer Res; 1997 Feb; 57(4):604-9. PubMed ID: 9044834
[TBL] [Abstract][Full Text] [Related]
3. p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.
Luedde T; Rodriguez ME; Tacke F; Xiong Y; Brenner DA; Trautwein C
Hepatology; 2003 Apr; 37(4):833-41. PubMed ID: 12668976
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
Schreiber M; Muller WJ; Singh G; Graham FL
Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
[TBL] [Abstract][Full Text] [Related]
6. [Cyclin-dependent kinase inhibitors in mammal cells].
Jiang H; Wang YC
Sheng Li Ke Xue Jin Zhan; 1996 Apr; 27(2):107-12. PubMed ID: 9592231
[TBL] [Abstract][Full Text] [Related]
7. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells.
Gill RM; Slack R; Kiess M; Hamel PA
Exp Cell Res; 1998 Oct; 244(1):157-70. PubMed ID: 9770359
[TBL] [Abstract][Full Text] [Related]
8. Under arrest at atomic resolution.
Morgan DO
Nature; 1996 Jul; 382(6589):295-6. PubMed ID: 8684452
[No Abstract] [Full Text] [Related]
9. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.
Ehmann GL; McLean TI; Bachenheimer SL
Virology; 2000 Feb; 267(2):335-49. PubMed ID: 10662629
[TBL] [Abstract][Full Text] [Related]
10. p27: a pleiotropic regulator of cellular phenotype and a target for cell cycle dysregulation in cancer.
Desdouets C; Bréchot C
Pathol Biol (Paris); 2000 Apr; 48(3):203-10. PubMed ID: 10858954
[TBL] [Abstract][Full Text] [Related]
11. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of cyclin E and cyclin-dependent kinase inhibitor (p27Kip1): effect on cell cycle regulation in HeLa cells.
Kwon TK; Nordin AA
Biochem Biophys Res Commun; 1997 Sep; 238(2):534-8. PubMed ID: 9299546
[TBL] [Abstract][Full Text] [Related]
13. Increased p27Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells.
Wu M; Bellas RE; Shen J; Yang W; Sonenshein GE
J Immunol; 1999 Dec; 163(12):6530-5. PubMed ID: 10586045
[TBL] [Abstract][Full Text] [Related]
14. Expression of G1 cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in androgen-induced prostate proliferation in castrated rats.
Chen Y; Robles AI; Martinez LA; Liu F; Gimenez-Conti IB; Conti CJ
Cell Growth Differ; 1996 Nov; 7(11):1571-8. PubMed ID: 8930407
[TBL] [Abstract][Full Text] [Related]
15. Expression of the v-Src oncoprotein in fibroblasts disrupts normal regulation of the CDK inhibitor p27 and inhibits quiescence.
Johnson D; Frame MC; Wyke JA
Oncogene; 1998 Apr; 16(15):2017-28. PubMed ID: 9591786
[TBL] [Abstract][Full Text] [Related]
16. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development.
Chellappan SP; Giordano A; Fisher PB
Curr Top Microbiol Immunol; 1998; 227():57-103. PubMed ID: 9479826
[No Abstract] [Full Text] [Related]
17. Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr CJ; Roberts JM
Genes Dev; 1995 May; 9(10):1149-63. PubMed ID: 7758941
[No Abstract] [Full Text] [Related]
18. Inactivation of cyclin-dependent kinase inhibitor genes and development of human acute leukemias.
Ragione FD; Iolascon A
Leuk Lymphoma; 1997 Mar; 25(1-2):23-35. PubMed ID: 9130611
[TBL] [Abstract][Full Text] [Related]
19. Roles of cyclin-dependent kinase inhibitors: lessons from knockout mice.
Kiyokawa H; Koff A
Curr Top Microbiol Immunol; 1998; 227():105-20. PubMed ID: 9479827
[No Abstract] [Full Text] [Related]
20. Overcoming inhibitions: subversion of CKI function by viral cyclins.
Swanton C; Card GL; Mann D; McDonald N; Jones N
Trends Biochem Sci; 1999 Mar; 24(3):116-20. PubMed ID: 10203759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
